The global cell and gene therapy manufacturing market size was valued at USD 11.70 billion in 2024 and is forecasted to reach around USD 116.39 billion by 2034, growing at a compound annual growth rate (CAGR) of 26.71% over the forecast period 2025 to 2034. The U.S cell and gene therapy manufacturing market size is estimated to reach around USD 44.60 billion by 2034 with a CAGR of 24.68%....